Introduction {#s0001}
============

The genus *Polygonum* (Polygonaceae) includes more than 200 species worldwide, mainly in areas of temperate climate. Several *Polygonum* species are used in traditional medicine in China and Japan to treat health disorders such as dysentery, articular pain and inflammation (Takasaki et al. [@CIT0065]; Kawai et al. [@CIT0025]; Fan et al. [@CIT0017]). Some species are also used in traditional medicine in Europe, Africa and Asia to treat diabetes (Soumyanath [@CIT0063]; Bothon et al. [@CIT0007]). In Europe, approximately 36 species of *Polygonum* can be found, including *P. maritimum* L., commonly known as sea knotgrass. Sea knotgrass is a perennial halophyte herb native from the sandy coasts of Europe, Mediterranean and Black Sea, Channel Islands, England and Belgium, occurring frequently throughout the Portuguese coast (Kilinc & Karaer [@CIT0027]; Caçador et al. [@CIT0008]). *Polygonum maritimum* has described antioxidant and antimicrobial activities (El-Haci et al. [@CIT0015]), and contains bioactive molecules such as polygonocinol, (+)-8-hydroxycalamene, octacosyl, triacontyl ferulate, arylpropane, quercetin, quercitrin, (+)-catechin, and sitosterol (Kazantzoglou et al. [@CIT0026]).

Diabetes is an emerging health problem in western societies affecting more than 300 million people worldwide and is expected to be the 7th cause of death by 2030 (Mathers & Loncar [@CIT0038]; Danaei et al. [@CIT0013]). Type 2 diabetes mellitus (T2DM) is mainly associated with genetics and lifestyle and encompasses more than 90% of all diabetes cases globally (Mozaffarian et al. [@CIT0044]). The major characteristic of T2DM is high blood glucose level, which is caused by congenital or acquired deficiency in secretion of insulin combined with decreased responsiveness to this hormone (WHO [@CIT0072]; Yarchoan & Arnold [@CIT0074]). The inhibition of carbohydrate-hydrolyzing enzymes, namely α-amylase and α-glucosidase, is thus an important strategy to manage hyperglycaemia linked to T2DM by decreasing the postprandial raise in blood glucose levels (Kwon et al. [@CIT0032]). Acarbose, miglitol and voglibose are clinically used compounds that target α-amylase and α-glucosidase; however, they present several side effects such as abdominal distension, flatulence and meteorism (Bischoff & Flower [@CIT0006]). In this sense, there has been a growing effort to search for novel natural compounds with antidiabetic properties and reduced side effects (Kwon et al. [@CIT0032]).

Hyperglycaemia found in T2DM patients may also induce metabolic disturbances leading to the development of oxidative stress and chronic inflammation states that contribute to diabetes-associated complications, namely, cardiovascular, urological, neurological, kidney and eyes disorders (American Diabetes Association [@CIT0003]; Vikram et al. [@CIT0070]). Oxidative stress coupled with reduced antioxidant defences enhances damage caused by free radicals, such as reactive oxygen species (ROS), and contributes to disease progression (Sabu & Kuttan [@CIT0058]; Maritim et al. [@CIT0036]). In this context, natural antioxidants can be useful in the prevention and/or management of oxidative stress-related disorders, including diabetes (Ruhe & McDonald [@CIT0057]; Fardoun [@CIT0018]). ROS also contributes to the production of pro-inflammatory cytokines and chemokines and to insulin resistance (Akash et al. [@CIT0002]; Muriach et al. [@CIT0046]). The role of oxidative stress and chronic inflammation in the progression of T2DM thus opens new avenues in the search for novel and combined therapies comprising the prevention of oxidative and inflammatory states (Akash et al. [@CIT0002]).

As stated before, several *Polygonum* species are used in traditional medicine to treat inflammation and diabetes. However, to the best of our knowledge, there is no information regarding the anti-inflammatory and/or antidiabetic potential of the sea knotgrass. In this context, we report for the first time a comparative evaluation of the antioxidant and anti-inflammatory potential and inhibitory activity on key enzymes relevant for hyperglycaemia (α-amylase and α-glucosidase) of extracts of sea knotgrass leaves and roots. The phytochemical characterization of the extracts is also presented.

Material and methods {#s0002}
====================

Chemicals, culture media and supplements {#s0003}
----------------------------------------

Sigma-Aldrich (Germany) supplied the 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS) radicals, sodium nitrite, lipopolysaccharide (LPS) from *Escherichia coli*, sulfanilamide, *N*-(1-Naphthyl) ethylenediamine dihydrochloride (NED) and 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT). Folin-Ciocalteau (F-C) phenol reagent and phosphoric acid were purchased from Merck (Germany). Lonza (Belgium) provided Roswell Park Memorial Institute (RMPI) 1640 medium, fetal bovine serum (FBS), [l]{.smallcaps}-glutamine and penicillin/streptomycin. Additional chemicals were acquired from VWR International (Belgium).

Sample collection {#s0004}
-----------------

Whole plants of *P. maritimum* were hand collected in Ludo, South of Portugal, in June 2013. The taxonomical classification was performed by the botanist Dr. Manuel J. Pinto from the National Museum of Natural History (University of Lisbon, Botanical Garden, Portugal) and a voucher specimen is kept in the herbarium of MarBiotech laboratory (MBH22). Plants were divided in roots and leaves, washed, oven dried for 3 days at 50 °C, powdered and stored at −20 °C.

Preparation of the extracts {#s0005}
---------------------------

Dried samples were separately extracted with methanol and dichloromethane (1:40, w/v), overnight at room temperature (RT), under stirring. The extracts were filtered (Whatman no. 4), and evaporated to dryness at 40 °C in a rotary evaporator under reduced pressure (BUCHI R-210, Flawil, Switzerland). The dried extracts were dissolved in the corresponding solvent at the concentration of 10 mg/mL to be used in the chemical characterization assays, or in dimethyl sulfoxide (DMSO) to be used in the bioactivity assays. All samples were stored at −20 °C until needed.

Gas chromatography and mass spectrometry (GC-MS) phytochemical analysis {#s0006}
-----------------------------------------------------------------------

The extracts (100 μL) were filtered (0.2 μm polytetrafluoroethylene membrane syringe filters), transferred to a glass vial and the solvent evaporated under a nitrogen stream. When dried, 50 μL of the derivatization reagent \[*N*-methyl-N-(trimethylsilyl) trifluoroacetamide; MSTFA\] was added. With the vial capped, the extracts were vortexed and heated for 20 min in a dry block heater at 40 °C (Pereira et al. [@CIT0052]).

The GC/MS analyses were performed on an Agilent 6890 series gas chromatograph equipped with an Agilent 7683 automatic liquid sampler coupled to an Agilent 5973 N mass selective detector (Agilent Technologies, Little Falls, DE). A programed temperature vaporization injector with a septumless sampling head (Gerstel, Mullheim a/d Ruhr, Germany) and a baffled liner was used, operating in the solvent vent mode with compressed air for inlet cooling. Large volume injection was performed (vent time, 0.30 min; flow, 50 mL/min; pressure, 0 psi; purge, 60 mL/min at 2 min), for which the inlet temperature was programed from 60 °C (0.4 min) to 300 °C (3 min isothermal) at a rate of 60 °C/min and subsequently decreased to 200 °C (held until end) at a rate of 50 °C/min. The injection volume and speed were set at 10 μL and 100 μL/min, respectively. GC analysis was performed on a Zebron ZB-5 (30 m × 0.25 mm I.D., 0.25 μm df; Phenomenex, USA) capillary column (5% phenyl, 95% polydimethylsiloxane), using helium as carrier gas maintained in a constant inlet pressure mode of 7.81 psi. The oven temperature was programed from 100 °C (1 min) at 20 °C/min to 250 °C, then at 10 °C/min to 300 °C and hold for 20 min. The transfer line, ion source and quadrupole analyzer temperatures were maintained at 280 °C, 230 °C and 150 °C, respectively and a solvent delay of 4 min was selected. In the full-scan mode, electron ionization mass spectra in the range 35-550 Da were recorded at 70 eV with an ionization current of 34.6 μA. Data recording and instrument control were performed by MSD ChemStation software (G1701CA; version C.00.00; Agilent Technologies).

Radical-scavenging activity (RSA) on DPPH^•^ {#s0007}
--------------------------------------------

The RSA against DPPH was determined according to the method described by Custódio et al. ([@CIT0011]). Extracts (22 μL at concentrations ranging from 60 to 1000 μg/mL) were mixed with 200 μL of DPPH solution (120 μM, in methanol) in 96-well microplates and incubated in the dark for 30 min (RT). The absorbance was measured at 517 nm (Biotek Synergy 4) and results presented as half maximal inhibitory concentration (IC~50~, μg/mL). Butylated hydroxytoluene (BHT) was used as a positive control.

RSA on ABTS^•+^ {#s0008}
---------------

The RSA against ABTS radical was evaluated by the method described previously (Rodrigues et al. [@CIT0056]). A stock solution of ABTS^•+^ (7.4 mM) was generated by reacting equal amounts of ABTS with potassium persulfate (2.6 mM) for 16 h in the dark at RT. The ABTS^•+^ solution was diluted with ethanol to obtain an absorbance of at least 0.7 at 734 nm (Biotek Synergy 4). Extracts (10 μL at concentrations from 60 to 1000 μg/mL) were mixed in 96-well microplates with 190 μL of ABTS^•+^ solution. After 6 min of incubation the absorbance was measured at 734 nm (Biotek Synergy 4). Results were expressed IC~50~ values (μg/mL). BHT was used as positive control.

RSA on nitric oxide (NO^•^) {#s0009}
---------------------------

The NO^•^ scavenging activity was evaluated according to Rodrigues et al. ([@CIT0056]) on extracts at concentrations between 60 and 1000 μg/mL. Samples (50 μL) were mixed with 50 μL of 10 mM sodium nitroprusside in phosphate buffer (PBS) and incubated for 90 min at RT. After, 50 μL of Griess reagent (1% of sulfanilamide and 0.1% of naphthylethylenediamine in 2.5% HPO~3~) were added. The absorbance was read at 546 nm, and results were expressed as IC~50~ values (μg/mL). *N*~ω~-Nitro-[l]{.smallcaps}-arginine methyl ester hydrochloride ([l]{.smallcaps}-NAME) was used as standard.

Copper (Cu^2+^) chelating activity (CCA) {#s0010}
----------------------------------------

The CCA was assessed using pyrocatechol violet as described previously (Rodrigues et al. [@CIT0056]). The extracts (30 μL) were applied at concentrations from 60 to 1000 μg/mL and mixed with 200 μL of 50 mM Na acetate buffer (pH 6), 6 μL of pyrocatechol violet (4 mM) in the above buffer and 100 μL of CuSO~4~·5H~2~O (50 μg/mL, in water). The change in the colour of the solution was measured at 632 nm using a microplate reader (Biotek Synergy 4). Results were expressed as IC~50~ values (μg/mL). Ethylenediamine tetraacetic acid (EDTA) was used as a positive control.

Iron (Fe^2+^) chelating activity (ICA) {#s0011}
--------------------------------------

The ICA chelating activity was determined by measuring the formation of the Fe^2+^ ferrozine complex (Megías et al. [@CIT0039]), according to Rodrigues et al. ([@CIT0056]). Extracts (30 μL at concentrations between 60 and 1000 μg/mL) were mixed in 96-well microplates with 200 μL of dH~2~O and 30 μL of a FeCl~2~ solution (0.1 mg/mL in water). After 30 min, 12.5 μL of ferrozine solution (40 mM in water) was added. The change in colour was measured in a microplate reader (Biotek Synergy 4) at 562 nm, and results were expressed as IC~50~ values (μg/mL). EDTA was used as standard.

Ferric reducing antioxidant power (FRAP) assay {#s0012}
----------------------------------------------

The ability of the extracts to reduce Fe^3+^ was assayed by the method described by Megías et al. ([@CIT0039]). Extracts (50 μL) were tested at concentrations ranging from 60 to 1000 μg/mL and mixed with distilled water (50 μL) and 1% potassium ferricyanide (50 μL). After an incubation of 20 min at 50 °C, 50 μL of 10% trichloroacetic acid (w/v) and ferric chloride solution (0.1%, w/v) were added and absorbance was measured at 700 nm. Increased absorbance of the reaction mixture indicates increased reducing power. Antioxidant activity was calculated relatively to the positive control (BHT; 1000 μg/mL), and expressed as IC~50~ values (μg/mL).

Cell culture and cell viability {#s0013}
-------------------------------

RAW 264.7 macrophages were maintained in RPMI culture medium supplemented with 10% heat-inactivated FBS, 1% [l]{.smallcaps}-glutamine (2 mM), and 1% penicillin (50 U/mL)/streptomycin (50 μg/mL), and were maintained at 37 °C in humidified atmosphere with 5% CO~2~. Exponentially growing cells were plated in 96-well tissue plates at a concentration of 1 × 10^4^ cells/well and incubated for 24 h. Extracts were then applied at different concentrations (3 to 100 μg/mL) for 24 h. Control cells were treated with DMSO at the highest concentration used in test wells (0.5%), and cell viability was determined by the MTT colorimetric assay (Mosmann [@CIT0043]). Briefly, 2 h prior to the end of the incubation period 20 μL of MTT (5 mg/mL in PBS) were added to each well and further incubated at 37 °C. Then, 150 μL of DMSO was added to each well in order to dissolve the formazan crystals and absorbance was measured at 590 nm (Biotek Synergy 4).

Measurement of NO production {#s0014}
----------------------------

The NO production was evaluated using RAW 264.7 macrophages as described by Rodrigues et al. ([@CIT0055]). Cells were plated at 2.5 × 10^5^ cells/mL in 96-well tissue plates and allowed to adhere overnight. Afterwards, they were treated with nontoxic concentrations of the extracts, i.e., those that allowed cellular viability higher than 80%, in serum- and phenol-free culture medium, containing 100 ng/mL of LPS, for 24 h (Nishishiro et al. [@CIT0047]). NO production was assessed using the Griess assay (Miranda et al. [@CIT0041]). A calibration curve was prepared with different concentrations of sodium nitrite (1.5--100 μM). Results were expressed as percentage (%) of NO production, relative to a control containing DMSO (0.5%, v/v), and as IC~50~ values (μg/mL).

α-Amylase inhibitory activity {#s0015}
-----------------------------

The α-amylase inhibitory activity was determined by the method described by Xiao et al. ([@CIT0073]). Samples (40 μL at concentrations ranging from 1000 to 10,000 μg/mL) were mixed in 96-well microplates with 40 μL of amylase solution (100 U/mL in 0.1 M sodium phosphate buffer, pH 7.0) and 40 μL of 0.1% starch solution (diluted in the previous buffer). After 10 min at 37 °C, 20 μL of 1 M hydrochloric acid (HCl) and 100 μL of iodide solution (5 mM iodine (I~2~) + 5 mM potassium iodide (KI), in distilled water) were added and the absorbance was measured at 580 nm. Results were expressed as IC~50~ values (μg/mL). Acarbose was used as the standard at concentrations between 250 and 10,000 μg/mL.

Baker's yeast α-glucosidase inhibitory activity {#s0016}
-----------------------------------------------

Microbial (*Saccharomyces cerevisiae*) α-glucosidase inhibitory activity was determined according to the method described by Custódio et al. ([@CIT0011]). Samples (50 μL at concentrations ranging from 20 and 1000 μg/mL) were mixed with 100 μL of enzyme solution (1.0 U/mL, in 0.1 M sodium phosphate buffer, pH 7.0), and incubated for 10 min at 25 °C. Then, 50 μL of 5 mM *p*-nitrophenyl-α-[d]{.smallcaps}-glucopyranoside (NGP; diluted in the previous buffer) were added and incubated more 5 min at 25 °C. The absorbance was recorded at 405 nm using a microplate reader (Biotek Synergy 4) and results were expressed as IC~50~ values (μg/mL). Acarbose was used as positive control at concentrations from 250 to 10,000 μg/mL.

Rat's intestinal α-glucosidase inhibitory activity {#s0017}
--------------------------------------------------

Rat's intestinal acetone powder was used as a crude enzyme extract as an example of enzyme of mammalian origin (Kwon et al. [@CIT0032]). Rat's intestinal acetone powder (250 mg) were mixed with 10 mL of 0.1 M sodium phosphate buffer (pH 7.0) and centrifuged at 5000 × *g* for 20 min at 4 °C. The supernatant (100 μL) was mixed with the extracts (50 μL at concentrations between 500 and 10,000 μg/mL), and incubated for 10 min at 25 °C. Then, 50 μL of 5 mM *p*-nitrophenyl-α-[d]{.smallcaps}-glucopyranoside (NGP; diluted in the previous buffer) was added and the mixture was incubated for 30 min at 37 °C. The absorbance was read at 405 nm using a microplate reader (Biotek Synergy 4), and results were expressed as IC~50~ values (μg/mL). Acarbose was used as positive control at concentrations from 250 to 10,000 μg/mL.

Statistical analysis {#s0018}
--------------------

Results were expressed as mean ± standard error of the mean (SEM), and experiments were carried out at least in triplicate. Significant differences were assessed by analysis of variance (ANOVA) followed by Duncan's New Multiple Range Test, or by Kruskal--Wallis test when parametricity of data did not prevail. SPSS statistical package for Windows (release 15.0, SPSS Inc.) was used. The IC~50~ values were calculated by sigmoidal fitting of the data in the GraphPad Prism v. 5.0 software.

Results {#s0019}
=======

Phytochemical analysis {#s0020}
----------------------

In order to determine their chemical composition, extracts were analyzed by GC-MS ([Figure 1](#F0001){ref-type="fig"} and [Table 1](#t0001){ref-type="table"}). This analysis was able to identify a large number of compounds detected in the methanol extracts (70--75%). However, a large percentage of compounds detected in the dichloromethane extracts could not be identified (45--48%). In total, 51 compounds were identified belonging to different classes of biochemicals: alkanes and alkenes (AA), fatty acids (FA), phenolic compounds (PC), acylglycerols (GLY), saccharides (SAC), alcohols (ALC), phytosterols (PS) and minor groups (MG).

![Main chemical compound classes identified by GC/MS in the dichloromethane and methanol extracts of roots and leaves of *P. maritimum*. (A) Methanol leaf extract; (B) Methanol root extract; (C) Dichloromethane leaf extract; and (D) Dichloromethane root extract. AA: alkanes and alkenes; FA: fatty acids; PC: phenolic compounds; GLY: acylglycerols; SAC: saccharides; ALC: alcohols; PS: phytosterols; MG: minor groups; NI: non-identified compounds.](IPHB_A_1301493_F0001_B){#F0001}

###### 

Phytochemical composition of the methanol and dichloromethane extracts of *P. maritimum* leaves and roots, determined by GC/MS analysis.

                                                                                                          Relative abundance (%)                 
  ------------------- ------- -------------------------------------------------------- ------------------ ------------------------ ------ ------ ------
  *Alkanes/Alkenes*                                                                                                                              
  **1**               5.61    2,6,11-Trimethyl dodecane                                C~15~H~32~                                  0.67           
  **2**               5.63    Phytane                                                  C~20~H~42~                                         0.22   0.21
  **3**               5.66    2,6,10,15-Tetramethyl heptadecane                        C~17~H~36~                                  0.72           
  **4**               6.75    Tetradecane                                              C~14~H~30~                                  0.97   0.32   0.40
  **5**               8.55    Cetane                                                   C~16~H~34~                                         0.16   0.18
  **6**               8.63    2-Methyl octadecane                                      C~19~H~40~                                  0.78   0.26    
  **7**               9.78    Octacosane                                               C~28~H~58~                                  0.77   0.37   0.70
  **8**               9.90    3,11-Dimethyl nonacosane                                 C~31~H~64~                                  1.10           
  **9**               11.57   Eicosane                                                 C~20~H~42~                                  0.90           
  **10**              12.39   Docosane                                                 C~22~H~46~                                  1.78          1.01
  **11**              12.40   Tricosane                                                C~23~H~48~                                         0.73    
  **12**              14.10   Pentacosane                                              C~25~H~52~                                         0.59    
  **13**              16.89   1-Nonadecene                                             C~19~H~38~                                         0.87    
  **14**              17.75   Nonacosane                                               C~29~H~60~                                         1.80    
  *Fatty acids*                                                                                                                                  
  **15**              5.75    Pelargonic acid                                          C~12~H~18~O~2~     0.28                                   0.17
  **16**              7.72    Lauric acid                                              C~12~H~24~O~2~     1.51                            0.25   0.23
  **17**              8.92    Myristic acid                                            C~14~H~28~O~2~     1.22                            1.72   0.65
  **18**              10.28   Palmitic acid                                            C~16~H~32~O~2~     6.40                     1.46   4.49   6.53
  **19**              11.08   Linoleic acid                                            C~18~H~32~O~2~     1.79                     2.32   0.35    
  **20**              11.18   Margaric acid                                            C~17~H~34~O~2~                                     0.14   0.20
  **21**              11.75   Oleic acid                                               C~18~H~34~O~2~     4.13                            2.32   3.21
  **22**              11.85   Linolenic acid                                           C~18~H~30~O~2~                                     0.95    
  **23**              11.94   Stearic acid                                             C~18~H~36~O~2~     6.71                     4.27   1.83   1.38
  **24**              13.59   Arachidic acid                                           C~20~H~40~O~2~     1.71                            1.05    
  **25**              15.32   Behenic acid                                             C~22~H~44~O~2~                                     1.35   2.64
  **26**              17.10   Lignoceric acid                                          C~24~H~48~O~2~     0.53                            1.29   1.78
  *Phenols*                                                                                                                                      
  **27**              5.09    Benzoic acid                                             C~7~H~7~O~2~       3.24                     0.51           
  **28**              6.94    Butylated hydroxytoluene                                 C~15~H~24~O        0.99                     1.31   0.17   0.27
  **29**              7.12    Vanillin                                                 C~8~H~8~O~3~                                              0.68
  **30**              7.70    Phloroglucinol                                           C~6~H~6~O~3~                                0.92           
  **31**              9.63    Methyl 3-(3,4-di-tert-butyl-4-hydroxyphenyl)propionate   C~18~H~28~O~3~     0.68                     0.66           
  **32**              9.69    Gallic acid                                              C~7~H~6~O~5~       1.15                            0.54   1.97
  *Acylglycerols*                                                                                                                                
  **33**              14.63   2-Monopalmitin                                           C~19~H~38~O~4~                                            1.28
  **34**              14.89   1-Monopalmitin                                           C~19~H~38~O~4~     5.89                     10.3   2.20   3.05
  **35**              16.14   2-Monostearin                                            C~19~H~38~O~4~     15.4                            0.34    
  **36**              16.27   1-Monoolein                                              C~21~H~40~O~4~     0.35                            0.47    
  **37**              16.59   1-Monostearin                                            C~19~H~38~O~4~     1.08                     24.1   2.87   5.44
  *Saccharides*                                                                                                                                  
  **38**              8.69    [d]{.smallcaps}-Fructose                                 C~6~H~7~O~6~       4.40                     0.97   0.39   0.27
  **39**              9.02    β-[d]{.smallcaps}-Glucofuranose                          C~6~H~12~O~6~      0.85                                    
  **40**              9.34    β-[d]{.smallcaps}-Glucopyranose                          C~6~H~12~O~6~      1.05                            0.14    
  **41**              9.41    α-[d]{.smallcaps}-Glucopyranose                          C~6~H~12~O~6~      0.45                                    
  *Alcohols*                                                                                                                                     
  **42**              4.12    Butane-1,3-diol                                          C~4~H~10~O~2~      0.62                                    
  **43**              5.18    Glycerol                                                 C~3~H~8~O~3~       5.20                     5.02           
  **44**              11.35   Phytol                                                   C~20~H~40~O        0.62                                    
  **45**              20.91   1-Octacosanol                                            C~28~H~58~O                                        8.72    
  *Phytosterols*                                                                                                                                 
  **46**              24.51   Stigmasterol                                             C~29~H~48~O                                        1.37    
  **47**              25.88   β-Sitosterol                                             C~29~H~50~O        5.90                     1.88   10.6   19.0
  *Minor groups*                                                                                                                                 
  **48**              5.25    Phosphoric acid                                          H~3~PO~4~          0.62                     0.55   0.46   0.34
  **49**              7.44    Diethyl phthalate                                        C~12~H~14~O~4~     0.35                                    
  **50**              7.78    Thymine                                                  C~5~H~6~N~2~O~2~                            0.46           
  **51**              13.11   Oleamide                                                 C~18~H~35~NO       0.89                     6.66   2.30   3.13

With similar contents, fatty acids (24.3%) and acylglycerols (22.8%) were the most represented categories in the methanol leaf extract (LM), in which 2-monostearin (**35**) was the major compound (15.4%). Palmitic acid (**18**), linolenic acid (**23**), 1-monopalmitin (**34**), glycerol (**43**), and β-sitosterol (**47**) were also detected at abundances higher than 5%. Acylglycerols were the most abundant constituents of the LM extract (34.4%), with 1-monostearin (**31**) being the most representative compound (24.0%), while 1-monopalmitin (**34**) and oleamide (**51**) represented 10.3 and 6.66% of the total identified components, respectively. In the dichloromethane leaf extract (LDCM), fatty acids represented 15.7% and phytosterols (PS) 12.0% of the total identified compounds. β-Sitosterol (**47**; 10.5%) and 1-octacosanol (**45**; 8.7%) were the major components identified. Similarly, the dichloromethane root extract (RDCM) had the highest content in phytosterols (PS; 19.0%) and fatty acids (FA; 16.7%), in which β-sitosterol (**47**, 19.0%) was the main component, followed by palmitic acid (**18**) and 1-monostearin (**37**) at 6.5 and 5.4%, respectively.

Antioxidant activity {#s0021}
--------------------

The *P. maritimum* LM and methanol root (RM) extracts showed high RSA for both DPPH and ABTS radicals, coupled with a strong capacity for reducing iron and chelating copper ([Table 2](#t0002){ref-type="table"}). In the DPPH assay, the methanol extracts of both organs had similar IC~50~ values (roots: 27 μg/mL; leaves: 26 μg/mL), which were significantly lower than the one obtained with the positive control (BHT, 110 μg/mL; [Table 2](#t0002){ref-type="table"}). Regarding the ABTS radical, both the RM and LM extracts had IC~50~ of 192 and 140 μg/mL, respectively, which were similar to that of BHT (140 μg/mL; [Table 2](#t0002){ref-type="table"}). The RM and LM had also high ability to reduce iron with IC~50~ values of 64 and 48 μg/mL, respectively ([Table 2](#t0002){ref-type="table"}). A moderate iron reduction was obtained upon addition of the RDCM (IC~50~ = 770 μg/mL) and LDCM (IC~50~ = 798 μg/mL) extracts. However, none of the extracts had the capacity for scavenging the NO radical or for chelating iron ([Table 2](#t0002){ref-type="table"}).

###### 

Radical scavenging activity (RSA) on DPPH, ABTS and NO radicals, metal chelating activity on iron (ICA) and copper (CCA) and ferric reducing activity (FRAP) activity of methanol (MeOH) and dichloromethane (DCM) extracts of roots and leaves of *P. maritimum.*

                           RSA      Metal chelation/reduction                                                        
  ------------------------ -------- --------------------------- ------------- ----------- ------------- ------------ -------------
  MeOH                     Leaves   26 ± 0.7^a^                 140 ± 6^a^    n.a.        290 ± 10^b^   n.a.         48 ± 1.4^a^
                           Roots    27 ± 0.0^a^                 192 ± 5^b^    n.a.        446 ± 8^c^    n.a.         64 ± 3.8^a^
  DCM                      Leaves   n.a.                        n.a.          n.a.        n.a.          n.a.         798 ± 36^b^
                           Roots    n.a.                        n.a.          n.a.        n.a.          n.a.         770 ± 53^b^
  BHT\*                    --       110 ± 10^b^                 140 ± 10^a^   --          --            --           --
  [l]{.smallcaps}-NAME\*   --       --                          --            2500 ± 10   --            --           --
  EDTA\*                   --       --                          --            --          170 ± 10^a^   55.9 ± 3.7   --

Results are expressed as IC~50~ values (μg/mL). \*Positive control; n.a.: not active. Values are means ± SEM of three separate experiments performed in triplicate (*n* = 9). In the same column, means labelled with different letters are significantly different by Duncan's multiple range test (*p* \< 0.05).

Anti-inflammatory activity {#s0022}
--------------------------

To assess the *in vitro* anti-inflammatory activity, the effect of applying nontoxic concentrations of the extracts (i.e. yielding cell viability \>80%) on the NO production by LPS-stimulated RAW 264.7 macrophage cells was determined. A significant reduction in cell viability was observed upon applying the LM extract at a concentration of 100 μg/mL to the cells. Loss of viability was also observed with the RDCM extract at 50 and 100 μg/mL (data not shown). Therefore, these concentrations were not used in the anti-inflammatory activity assessment.

Exposure of RAW 264.7 cells to LPS at 100 ng/mL increased the nitrite concentration in the culture medium from a basal level of approximately 0.3 μM to around 13 μM (data not shown). This increase was significantly reduced in a dose-dependent manner by the treatment with LDCM, at concentrations ranging from 25 to 100 μg/mL, showing that the latter had an activity similar to the positive control ([l]{.smallcaps}-NAME) at the same concentration ([Figure 2](#F0002){ref-type="fig"}). However, this extract had an IC~50~ value of 48 μg/mL, higher than that of [l]{.smallcaps}-NAME (29.1 μg/mL; data not shown). Interestingly, incubating this cell line with the remaining extracts resulted in an increase in NO production when compared to the control ([Figure 2](#F0002){ref-type="fig"}). In particular, incubation with LM and RM extracts resulted in the most significant increases in NO production: 144% at the concentration of 50 μg/mL and 139% at 25 μg/mL, respectively.

![Effect of the application of dichloromethane and methanol extracts of roots and leaves of *P. maritimum* on NO production (%) by LPS-stimulated macrophages. Control cells were treated with culture medium supplemented with 0.5% DMSO and 100 ng/mL of LPS. [l]{.smallcaps}-NAME (positive control) was applied at the concentration of 100 μg/mL. Solid and errors bars represent the average and SEM, respectively (*n* = 9). Bars followed by different letters are significantly different according to the Duncan's multiple ranges test (*p* \< 0.05).](IPHB_A_1301493_F0002_B){#F0002}

Antidiabetic activity {#s0023}
---------------------

The inhibitory potential of extracts from *P. maritimum* was evaluated against α-amylase and baker's yeast and rat's α-glucosidases ([Table 3](#t0003){ref-type="table"}). The methanol extracts had the highest capacity to inhibit the baker's yeast α-glucosidase with IC~50~ values of 19 and 29 μg/mL for roots and leaves, respectively, which were significantly lower than that of acarbose (IC~50~ = 3144 μg/mL). Despite the fact that methanol extracts had no capacity to inhibit rat's α-glucosidase, LDCM had the highest rat's α-glucosidase inhibitory activity (IC~50~ = 2527 μg/mL), which was a significantly lower IC~50~ value than that of acarbose (4638 μg/mL; *p* \< 0.05).

###### 

Inhibitory activity of dichloromethane and methanol extracts of roots and leaves of *P. maritimum* on α-amylase, baker's yeast α -glucosidase and rat's intestinal α-glucosidase.

  Extract/Standard   Organ    α-Amylase   Yeast α-glucosidase   Rat α-glucosidase
  ------------------ -------- ----------- --------------------- -------------------
  Methanol           Leaves   n.a.        29 ± 0.7^a^           n.a.
                     Roots    n.a.        19 ± 0.5^a^           n.a.
  Dichloromethane    Leaves   n.a.        585 ± 27^b^           2527 ± 37
                     Roots    n.a.        626 ± 14^b^           \>2500
  Acarbose\*                  7797 ± 98   3144 ± 132^c^         4638 ± 438

Results are expressed as IC~50~ values (μg/mL). \*Positive control; n.a.: not active. Values are means ± SEM of three separate experiments performed in triplicate (*n* = 9). In the same column, means labelled with different letters are significantly different by Duncan's multiple range test (*p* \< 0.05).

Discussion {#s0024}
==========

In order to confirm the use of *Polygonum* species in traditional medicine in the treatment of inflammation and diabetes, we assessed for the first time the phytochemical composition of *P. maritimum* and its *in vitro* anti-inflammatory and antidiabetic potential.

GC-MS analysis detected alkanes, alkenes and fatty acids as the major categories of compounds in *P. maritimum* extracts. These are lipophilic compounds widely distributed in plants as constituents of plant waxes and have been described in the halophilic Mediterranean *Suaeda vera* Forssk. ex J.F.Gmel. (Amaranthaceae), *Sarcocornia fruticosa* (L.) A.J.Scott (Amaranthaceae), and *Halimione portulacoides* (L.) Aellen (Amaranthaceae) (Grossi & Raphel [@CIT0022]). Waxes usually have a protective role, for example, against microbial infections and avoiding excessive water losses and acute osmotic stress that halophilic species suffer while growing in drenched soils (Müller & Riederer [@CIT0045]; Huang et al. [@CIT0023]). Moreover, they are common constituents of essential oils of halophyte species, such as *Suaeda fructicosa* and *Limonium echioides* (L.) Mill. (Plumbaginaceae) (Saïdana et al. [@CIT0059]). From the compounds detected in this study, only β-sitosterol (**47**) had been previously identified in *P. maritimum* also in dichloromethane extracts. Phytol (**44**), palmitic (**18**) and lauric (**16**) acids were also previously detected as components of essential oils of *Polygonum* species, namely *P. hydropiper* L. and *P. minus* Huds. (Miyazawa & Tamura [@CIT0042]; Baharum et al. [@CIT0004]).

Our findings showed that *P. maritimum* has a strong antioxidant activity comparable to that reported by other authors for similar extracts made from aerial parts of the same species (El-Haci et al. [@CIT0015]) and *P. sachalinensis* F.Schmidt and *P. cuspidatum* Siebold & Zucc. (Pan et al. [@CIT0051]; Fan et al. [@CIT0017]). Moreover, IC~50~ values obtained with the RM and LM were significantly lower than or similar to the one obtained with the positive control (BHT) for DPPH and ABTS assays, respectively. The significantly higher antioxidant activity of these extracts can be related to the presence of some of the compounds identified in these extracts, namely, the phenolic compounds benzoic acid, BHT, vanillin and phloroglucinol, since these compounds are well described as strong antioxidants *in vitro* (Foti [@CIT0019]; Dai & Mumper [@CIT0012]). Phytol and linolenic acid have also been described as potent *in vitro* and *in vivo* antioxidants due to their hydroxyl group (Richard et al. [@CIT0054]; Santos et al. [@CIT0060]). Thus, their presence in the LM could also contribute to the high RSA and ICA of this extract. Interestingly, no significant differences were observed between the antioxidant activity of leaves and roots as opposed to that reported for other halophytes species, such as *Mesembryanthemum edule* L. (Aizoaceae)*, Limoniastrum monopetalum* (L.) Boiss. (Plumbaginaceae)*, Salsola kali* L. (Chenopodiaceae)*, Tamarix gallica* L. (Tamaricaceae) and *Limonium algarvense* Erben (Plumbaginaceae) (Ksouri et al. [@CIT0030]; Falleh et al. [@CIT0016]; Trabelsi et al. [@CIT0066]; Rodrigues et al. [@CIT0056]). This can be explained by the similar phytochemical profile of the methanol extracts of both organs ([Figure 1](#F0001){ref-type="fig"} and [Table 1](#t0001){ref-type="table"}), suggesting that the bioactive compound(s) are not organ-specific.

LPS is a cell wall endotoxin produced by Gram-negative bacteria that activates macrophages to produce inflammatory mediators such as NO (Martich et al. [@CIT0037]), a radical associated with chronic inflammation (Kubes [@CIT0031]; Joo et al. [@CIT0024]). In this context, a decrease in NO production is used as an indicator of the potential for the extracts to reduce an inflammatory response (Joo et al. [@CIT0024]; Rodrigues et al. [@CIT0055]). On the other hand, an increase in NO production can indicate an immunostimulatory effect of the extracts, which is important in macrophage defence and protection against infection (Wink et al. [@CIT0071]).

The anti-inflammatory effect of *P. maritimum* leaves may be attributed to the presence of compound(s) with potential anti-inflammatory properties, most likely β-sitosterol, stigmasterol, 1-octacosanol, oleamide as well as linolenic and oleic acids ([Table 1](#t0001){ref-type="table"}). For instance, β-sitosterol, one of the major constituents of this extract, has anti-inflammatory properties through TNF-α inhibition (Loizou et al. [@CIT0035]), and so do 1-octacosanol and oleic acid (Vassiliou et al. [@CIT0068]; de Oliveira et al. [@CIT0014]). In turn, linolenic acid and oleamide are able to reduce NO production and inducible nitric oxide synthase (iNOS) gene expression, through the inhibition of the NF-κB pathway (Ren & Chung [@CIT0053]; Oh et al. [@CIT0048]). Stigmasterol was also reported to inhibit the production of pro-inflammatory mediators associated with the same pathway (Gabay et al. [@CIT0020]). The combination of all these compounds in the LDCM of *P. maritimum* are probably contributing to its NO inhibitory capacity, since they were solely identified in this extract, or in higher quantities ([Figure 2](#F0002){ref-type="fig"}). These findings are in accordance with several reports on the anti-inflammatory properties of *Polygonum* species (*P. lapathifolium L., P. cuspidatum* and *P. perfoliatum* L. (Takasaki et al. [@CIT0065]; Kim et al. [@CIT0028]; Fan et al. [@CIT0017]; Lei et al. [@CIT0034]).

NO has an important role in the immune system modulation, being one of the macrophage-mediated primary responses against pathogens such as fungi, helminthes, protozoa and bacteria (Wink et al. [@CIT0071]). In this sense, the increased NO production suggests that both the LM and RM from *P. maritimum* may have immunostimulatory properties (Wink et al. [@CIT0071]) most likely due to the presence of specific molecules in these extracts, namely, saturated fatty acids (stearic and palmitic acids), which are known inducers of the production of pro-inflammatory cytokines in macrophages (Valdearcos et al. [@CIT0067]; Miao et al. [@CIT0040]). In fact, immunostimulatory properties are reported in *P. multiflorum, P. minus* and *P. cuspidatum* (Chen et al. [@CIT0009]; Veerasamy et al. [@CIT0069]; Chueh et al. [@CIT0010]).

Compounds with the capacity to inhibit carbohydrate-hydrolyzing enzymes like α-amylase and α-glucosidase can delay the digestion of carbohydrates, decreasing the postprandial increase of blood glucose level after a mixed carbohydrate meal, and therefore can be an important strategy in managing hyperglycaemia linked to T2DM (Krentz & Bailey [@CIT0029]; Kwon et al. [@CIT0032]; Bhandari & Ansari [@CIT0005]).

It is noteworthy that methanol extracts were approximately 100-fold more active towards baker's yeast α-glucosidase than acarbose and that the LDCM had 2-times more ability to inhibit rat's α-glucosidase. High IC~50~ values for acarbose against this enzyme have also been reported by other authors (4823 μg/mL) (Gao et al. [@CIT0021]). However, the methanol extracts had no capacity to inhibit rat´s α-glucosidase, which is a common feature of molecules with inhibitory capacity on α-glucosidase from microbial origin (Oki et al. [@CIT0049]; Shai et al. [@CIT0061]). Furthermore, a few *in vitro* studies have discussed the low capacity of acarbose to inhibit mammalian α-glucosidase compared to crude extracts, including aqueous ethanol extracts from *P. senegalensis* (Meisn.) Soják (Polygonaceae), which is used in folk medicine to treat T2DM (Shinde et al. [@CIT0062]; Bothon et al. [@CIT0007]). Those differences are usually attributed to additive or synergistic interactions of the compounds present in the extracts, resulting in a higher capacity to inhibit the mammalian α-glucosidase (Adisakwattana et al. [@CIT0001]). The higher activity of the LDCM can be related with the presence of some particular compounds. For example, β-sitosterol was the main compound identified in this extract ([Table 1](#t0001){ref-type="table"}) and was previously reported to possess strong hypoglycaemic activity through α-glucosidase inhibition (Ortiz-Andrade et al. [@CIT0050]). The same properties were described for stigmasterol and linolenic acid, present only in this extract, as well as for oleic acid (Ortiz-Andrade et al. [@CIT0050]; Lean Teik et al. [@CIT0033]; Su et al. [@CIT0064]). In fact, Su et al. ([@CIT0064]) reported that linolenic and oleic acids were more active than acarbose. Although none of the extracts achieved 50% of inhibitory activity in the α-amylase assay, our data suggest that *P. maritimum* may have potential as a source of antidiabetic molecules. This is in accordance with the antidiabetic activity found in several *Polygonum* species, such as *P. aviculare* L. (Polygonaceae)*, P. cuspidatum, P. multiflorum* and *P. senegalensis* (Soumyanath [@CIT0063]; Bothon et al. [@CIT0007]).

Conclusions {#s0025}
===========

The present study highlights for the first time the potential of the halophyte *P. maritimum* as a source of compounds with antioxidant, anti-inflammatory and antidiabetic activities. The methanol extracts had the highest antioxidant capacity, possibly due to the presence of benzoic acid, BHT, phloroglucinol, phytol and linolenic acid. The dichloromethane extracts from *P. maritimum* leaves had significant anti-inflammatory activity, most likely related to its main constituents identified as β-sitosterol, stigmasterol, 1-octacosanol, oleamide, linolenic and oleic acids. Moreover, its high α-glucosidase inhibitory activity may be related to the presence of β-sitosterol, stigmasterol, linolenic and oleic acid. Overall, our results indicate that *P. maritimum* extracts are endowed with compounds with potential to be used as a combined strategy to manage T2DM due to its anti-inflammatory, antioxidant and α-glucosidase inhibitory properties. These results could be the starting points to further explore *P. maritimum*, especially its leaves, as a source of value-added bioactive natural products. Nonetheless, isolation and identification of the molecules(s) responsible for the detected biological activities is already being pursued.
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